Intelligent Bio Solutions Total Current Liabilities 2020-2025 | INBS

Intelligent Bio Solutions total current liabilities from 2020 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.

Intelligent Bio Solutions Total Current Liabilities 2020-2025 | INBS

Intelligent Bio Solutions total current liabilities from 2020 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$146.8B
CVS Health (CVS)$91.2B
Elevance Health (ELV)$69.8B
Cencora (COR)$56.3B
DiDi Global (DIDIY)$26.4B
Labcorp Holdings (LH)$23.2B
Natera (NTRA)$22.4B
BioMerieux (BMXMF)$17.4B
EUROFINS SCIENT (ERFSF)$14.9B
ICON (ICLR)$14.1B
Medpace Holdings (MEDP)$13.3B
CochLear (CHEOY)$13B
Solventum (SOLV)$12.6B
Viatris (VTRS)$12.1B
Caris Life Sciences,�Inc (CAI)$10.7B
Revvity (RVTY)$10.3B
Avantor (AVTR)$9B
Charles River Laboratories (CRL)$8B
Sonic Healthcare (SKHHY)$7.8B
HealthEquity (HQY)$7.6B
Bausch + Lomb (BLCO)$5.2B
Sotera Health (SHC)$4.7B
BrightSpring Health Services (BTSG)$4.2B
Amplifon S.p.A (AMFPF)$3.9B
GeneDx Holdings (WGS)$3.7B
Alignment Healthcare (ALHC)$3.2B
Concentras Parent (CON)$3B
Surgery Partners (SGRY)$2.9B
Organon (OGN)$2.4B
KindlyMD (NAKA)$2.4B